Study supports broader lab use of gyrA PCR for canine Campylobacter

A newly published inter-laboratory study suggests veterinary diagnostic labs are closer to having a practical, reproducible molecular test for detecting Campylobacter jejuni in canine feces. In the study, published online in 2026 in the Journal of Veterinary Diagnostic Investigation, 27 analysts at 19 laboratories successfully used a gyrA real-time PCR assay to detect C. jejuni across a range of inoculum levels, supporting the assay’s transferability beyond the originating lab. (journals.sagepub.com)

The paper lands in a public health context shaped in part by the U.S. multidrug-resistant Campylobacter jejuni outbreak linked to puppy exposure from 2016 through 2018. CDC investigators tied that outbreak to puppies sold through pet stores and warned that dogs can serve as a source of multidrug-resistant Campylobacter infection in people. The agency also noted that public health responders issued testing recommendations for puppies to veterinarians during the outbreak, highlighting the need for reliable canine fecal diagnostics. (cdc.gov)

That need has been building through a series of method-development studies from the same research group. According to the new paper, the authors had previously found that a cpn60 real-time PCR assay using DNA extracted directly from canine feces outperformed culture, with a limit of detection of 320 cfu/g. They later reported that a gyrA real-time PCR assay achieved a lower limit of detection, 40 cfu/g, during outbreak investigation work. In the current inter-laboratory exercise, samples containing 45,600 cfu/g were called positive by 100% of analysts, while samples at 4,700, 460, and 200 cfu/g were correctly identified by 96%, 77%, and 40% of analysts, respectively. (journals.sagepub.com)

The broader technical arc also matters. In a related JVDI publication, the same group evaluated semi-automated DNA extraction, added an internal positive control before extraction, and multiplexed the gyrA assay with that control without reducing assay performance. That earlier study also extended the method into bovine feces, suggesting the investigators have been working systematically to make the platform more robust, more scalable, and easier for routine diagnostic settings to use. Taken together, the studies point to a deliberate push from proof-of-concept toward operational lab readiness. (journals.sagepub.com)

Outside the assay-development papers, the industry backdrop supports that direction. Reviews of companion-animal campylobacteriosis have noted that culture methods in diagnostic labs can be biased and that molecular methods can improve rapid, accurate diagnosis. Earlier canine isolate work has also documented antimicrobial resistance in C. jejuni from dogs, which raises the stakes for getting detection right when cases intersect with households, shelters, breeding operations, or commercial distribution networks. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this is less about adding another esoteric PCR and more about closing a surveillance blind spot. Canine feces aren't routinely tested for C. jejuni, yet the organism sits at the intersection of diarrhea workups, zoonotic risk, antimicrobial stewardship, and outbreak response. A standardized assay with lower analytical limits and demonstrated inter-laboratory performance could help diagnostic labs move faster than culture, reduce opportunities for cross-contamination associated with enrichment-based workflows, and generate more consistent data across institutions. That, in turn, could improve case recognition and make it easier for clinicians to counsel pet parents about hygiene, exposure risk, and follow-up when human household members are also sick. (journals.sagepub.com)

The study does have a practical nuance: performance dropped as organism burden decreased, with only 40% of analysts correctly identifying samples at 200 cfu/g. That doesn't undercut the assay’s value, but it does remind labs that implementation details, analyst training, extraction quality, and threshold setting still matter. In other words, the assay appears promising for broader use, but its impact will depend on how well laboratories validate and operationalize it in their own hands. This is an inference based on the reported inter-laboratory performance pattern. (journals.sagepub.com)

What to watch: The next signal will be whether major veterinary diagnostic laboratories, reference labs, or surveillance networks incorporate gyrA PCR into routine canine enteric testing, especially for outbreak investigations, shelter medicine, commercial dog populations, or cases with clear zoonotic concern. If adoption follows, this paper could mark a meaningful step toward more consistent One Health detection of canine-associated Campylobacter jejuni. (journals.sagepub.com)